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The Rise and Fall of MAIT Cells with Age
To the Editor,
We read with interest the article by Novak et al.
recently published in the Scandinavian Journal of Immu-
nology and write in support of their data.
The authors describe the profound changes with age of
peripheral circulating mucosal associated invariant T
(MAIT) cells in a cohort of patients whose samples were
obtained post-clinical analysis [1]. We conducted a similar
study of a cohort of 160 patients aged <1–90 years (mean
41 years) a number of years ago of patients attending the
John Radcliffe Hospital in Oxford, UK where we
performed whole blood antibody staining of samples
post-clinical analysis. Unlike Novak et al., we did not
know the patient background and were unable to exclude
patients with infective or inflammatory conditions, how-
ever, similarities between the data sets and also this
recently published paper [2] are striking.
Novak et al. describe the MAIT cell population as
CD3+CD161++Va7.2+ cells; however, the na€ıve
CD3+CD161++ population in cord blood has polyclonal
T cell receptor usage and mature Va7.2+ and Va7.2-
CD161++ T cell subsets share the same distinctive
phenotype and function of the MAIT population [3, 4].
Our study was conducted before wider availability of the
Va7.2 antibody and describes the CD3+CD161++CD8a+
population that includes both Va7.2+ and Va7.2- cells,
representing about 90% of the MAIT cell population, with
the remainder predominantly double negative CD4-CD8-
cells (DN) [3]. We found a significant positive correlation
between peripheral blood CD3+CD161++CD8a+ cell
frequency and age up 30 years (r = 0.4651, P < 0.0001)
and subsequently a significant negative correlation between
MAIT cell frequency and age in those patients ≥30 years
(r = 0.5171, P < 0.0001) (Fig. 1A).
CD8 can be expressed as both a CD8ab heterodimer or a
CD8aa homodimer and the CD3+CD161++CD8a+/MAIT
population further subdivides into CD8a+b -/low (CD8ab
and CD8aa expressing) and CD8a+b- (CD8aa single
positive) subsets [3, 5, 6]. On further analysis, here, we
describe the CD161++CD8a+CD8b- subset to vary
in a similar pattern with age to the overall
CD3+CD161++CD8a+ subset (<30 years r = 0.45358
P < 0.0001; ≥ 30 years r = 0.5878 P < 0.0001)
(Fig. 1B) and a significant positive correlation between the
size of the CD161++CD8a+b+ and the CD161++CD8a+b-
as a proportion of CD3+ cells (Fig. 1C). Novak et al.
describe a fall in CD8a+ MAIT cells and increase in
proportion of DN MAITs with increasing age. Our own
previously published data would indicate CD161++CD8aa
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Figure 1 Variation with age of peripheral CD3+CD161++CD8a+ T
cells. (A) Correlation between age and the size of the
CD3+CD161++CD8a+b+ subset as a proportion of CD3+CD8a+b+ T
cells in patients < or ≥30 years old. (<30 years r = 0.4651, P < 0.0001;
≥30 years r = 0.5171, P < 0.0001 Spearman’s rank). (B) Correlation
between age (years) and the size of the CD3+CD161++CD8a+b- subset as
a proportion of CD3+CD161++CD8a+ T cells < or ≥30 years old
(<30 years r = 0.5358 P < 0.0001; ≥30 years r = 0.5878 P < 0.0001
Spearman’s rank). (C) Relationship between CD161++CD8a+b+ and
CD161++CD8a+b- subsets as a proportion of CD3+ cells (r2 = 0.1151,
P<0.0001 Linear regression).
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MAIT cells to be derived from CD161++CD8ab cells;
however, the origin of the DN subset is not known [3]. Our
data would indicate that the proportion of CD161++CD8aa
subset remains in a steady state as a proportion of
CD161++CD8a+ MAIT population overall, regardless of
possible progression to DN status.
Our data strongly support the conclusions of the authors
that further work involvingMAIT cells should ensure careful
age and sex-matched controls are used to allow for appro-
priate interpretation of data suggesting changes in MAIT
cell frequency within particular disease states; uncontrolled
studies of MAIT cells require cautious interpretation.
Yours Sincerely,
Dr Lucy Walker,
Dr Hannah Tharmalingham,
Professor Paul Klenerman
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